Startup Professionals Musings

AUGUST 24, 2011

Business incubators for sharing services were all the rage back in the days of the dot-com bubble (700 for profit, many more non-profit). Now they are coming back, and the best even provide networking, technical leadership, and seed funding, as well as investors waving money at graduates.

Incubator 93

Incubator Startup Seed Funding Mentor 93

Startup Professionals Musings

AUGUST 2, 2010

Business incubators for sharing services were all the rage back in the days of the dot-com bubble (700 for profit, many more non-profit). Now they are coming back, and the best even provide networking, technical leadership, and seed funding, as well as shared facilities and space.

Incubator 93

Incubator Startup Seed Funding Mentor 93

Startup Professionals Musings

OCTOBER 8, 2012

Business incubators for sharing services were all the rage back in the days of the dot-com bubble (700 for profit, many more non-profit). Now they are coming back, and the best even provide networking, technical leadership, and seed funding, as well as investors waving money at graduates.

Entrepreneur 86

Entrepreneur Incubator Startup Seed Funding 86

socalTECH

OCTOBER 24, 2011

One of the biggest complaints you hear from both entrepreneurs and investors in Los Angeles, is the lack of a credible, visible startup accelerator in the Los Angeles area. We caught up with Erik to hear more about MuckerLab, and its efforts to grow the Los Angeles technology ecosystem. Erik, thanks for the time.

Technical Advisors 176

Technical Advisors Startup Southern California Los Angeles 176

Both Sides of the Table

AUGUST 30, 2010

My original thinking from Oct ’09 was, while I didn’t (and still don’t) have a crystal ball I worried that: consumers were over-stretched with debt (and make up 77% of the economy), unemployment would continue to rise, which in turn would drive the stock market south and cut the rate of M&A activity and VC investment even further.

Entrepreneur 298

Entrepreneur Venture Capital Technical Review Startup 298

Xconomy

JUNE 3, 2016

It was fitting this week that, in the lead-up to two of biomedicine’s biggest self-celebrations, we were served ample reminder of the industry’s expensive decisions gone wrong. Shares of competitor Relypsa (NASDAQ: RLYP ) are up more than 25 percent since the ZS-9 decision.

San Diego 62

San Diego Patents Acquisition News 62